Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps.

Tan BK, Li QZ, Suh L, Kato A, Conley DB, Chandra RK, Zhou J, Norton J, Carter R, Hinchcliff M, Harris K, Peters A, Grammer LC, Kern RC, Mohan C, Schleimer RP.

J Allergy Clin Immunol. 2011 Dec;128(6):1198-1206.e1. doi: 10.1016/j.jaci.2011.08.037.

2.

Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps.

Kato A, Peters A, Suh L, Carter R, Harris KE, Chandra R, Conley D, Grammer LC, Kern R, Schleimer RP.

J Allergy Clin Immunol. 2008 Jun;121(6):1385-92, 1392.e1-2. doi: 10.1016/j.jaci.2008.03.002.

3.

Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.

Ho J, Bailey M, Zaunders J, Mrad N, Sacks R, Sewell W, Harvey RJ.

Clin Exp Allergy. 2015 Feb;45(2):394-403. doi: 10.1111/cea.12462.

PMID:
25429730
4.

Nasal biomarker profiles in acute and chronic rhinosinusitis.

Riechelmann H, Deutschle T, Rozsasi A, Keck T, Polzehl D, Bürner H.

Clin Exp Allergy. 2005 Sep;35(9):1186-91.

PMID:
16164446
5.

A role for anti-BP180 autoantibodies in chronic rhinosinusitis.

Jeffe JS, Seshadri S, Hamill KJ, Huang JH, Carter R, Suh L, Hulse KE, Norton J, Conley DB, Chandra RK, Kern RC, Jones JC, Schleimer RP, Tan BK.

Laryngoscope. 2013 Sep;123(9):2104-11.

6.

Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps.

Poposki JA, Uzzaman A, Nagarkar DR, Chustz RT, Peters AT, Suh LA, Carter R, Norton J, Harris KE, Grammer LC, Tan BK, Chandra RK, Conley DB, Kern RC, Schleimer RP, Kato A.

J Allergy Clin Immunol. 2011 Jul;128(1):73-81.e4. doi: 10.1016/j.jaci.2011.03.017.

7.

IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.

Shin HW, Kim DK, Park MH, Eun KM, Lee M, So D, Kong IG, Mo JH, Yang MS, Jin HR, Park JW, Kim DW.

J Allergy Clin Immunol. 2015 Jun;135(6):1476-85.e7. doi: 10.1016/j.jaci.2015.01.003.

PMID:
25725991
8.

Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4.

Soyka MB, Wawrzyniak P, Eiwegger T, Holzmann D, Treis A, Wanke K, Kast JI, Akdis CA.

J Allergy Clin Immunol. 2012 Nov;130(5):1087-1096.e10. doi: 10.1016/j.jaci.2012.05.052.

PMID:
22840853
9.

Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules.

Park SJ, Jun YJ, Lee KJ, Hwang SM, Kim TH, Lee SH, Lee SH.

Am J Rhinol Allergy. 2014 May-Jun;28(3):199-207. doi: 10.2500/ajra.2014.28.4032.

PMID:
24980231
10.

Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps.

Peterson S, Poposki JA, Nagarkar DR, Chustz RT, Peters AT, Suh LA, Carter R, Norton J, Harris KE, Grammer LC, Tan BK, Chandra RK, Conley DB, Kern RC, Schleimer RP, Kato A.

J Allergy Clin Immunol. 2012 Jan;129(1):119-27.e1-9. doi: 10.1016/j.jaci.2011.08.021.

11.

Downregulation of polymeric immunoglobulin receptor and secretory IgA antibodies in eosinophilic upper airway diseases.

Hupin C, Rombaux P, Bowen H, Gould H, Lecocq M, Pilette C.

Allergy. 2013 Dec;68(12):1589-97. doi: 10.1111/all.12274.

12.

Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps.

Keswani A, Chustz RT, Suh L, Carter R, Peters AT, Tan BK, Chandra R, Kim SH, Azam T, Dinarello CA, Kern RC, Schleimer RP, Kato A.

Allergy. 2012 Jan;67(1):25-32. doi: 10.1111/j.1398-9995.2011.02706.x.

13.

Increased CXCL10 expression in nasal fibroblasts from patients with refractory chronic rhinosinusitis and asthma.

Yoshikawa M, Wada K, Yoshimura T, Asaka D, Okada N, Matsumoto K, Moriyama H.

Allergol Int. 2013 Dec;62(4):495-502. doi: 10.2332/allergolint.13-OA-0572.

14.

Anticytokine autoantibodies in chronic rhinosinusitis.

Tsybikov NN, Egorova EV, Kuznik BI, Fefelova EV, Magen E.

Allergy Asthma Proc. 2015 Nov-Dec;36(6):473-80. doi: 10.2500/aap.2015.36.3880.

PMID:
26534753
15.

Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.

Jun YJ, Park SJ, Kim TH, Lee SH, Lee KJ, Hwang SM, Lee SH.

J Allergy Clin Immunol. 2014 Oct;134(4):926-934.e6. doi: 10.1016/j.jaci.2014.03.033.

PMID:
24810847
16.

Local free light chain expression is increased in chronic rhinosinusitis with nasal polyps.

Groot Kormelink T, Calus L, De Ruyck N, Holtappels G, Bachert C, Redegeld FA, Gevaert P.

Allergy. 2012 Sep;67(9):1165-72. doi: 10.1111/j.1398-9995.2012.02866.x.

17.

Endogenous production of hydrogen sulfide in human sinus mucosa and its expression levels are altered in patients with chronic rhinosinusitis with and without nasal polyps.

Hwang JW, Jun YJ, Park SJ, Kim TH, Lee KJ, Hwang SM, Lee SH, Lee HM, Lee SH.

Am J Rhinol Allergy. 2014 Jan-Feb;28(1):12-9. doi: 10.2500/ajra.2014.28.3972.

PMID:
24717871
18.

Role of local immunoglobulin E specific for Alternaria alternata in the pathogenesis of nasal polyposis.

Sabirov A, Hamilton RG, Jacobs JB, Hillman DE, Lebowitz RA, Watts JD.

Laryngoscope. 2008 Jan;118(1):4-9.

PMID:
17989579
19.

Local increase in IgE and class switch recombination to IgE in nasal polyps in chronic rhinosinusitis.

Baba S, Kondo K, Toma-Hirano M, Kanaya K, Suzukawa K, Ushio M, Suzukawa M, Ohta K, Yamasoba T.

Clin Exp Allergy. 2014;44(5):701-12. doi: 10.1111/cea.12287.

PMID:
24931597
20.

Supplemental Content

Support Center